Overview

A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors

Status:
Completed
Trial end date:
2007-07-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the bioequivalence of the new oral capsule formulation to the currently used oral capsule formulation of topotecan.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Topotecan